Quick Guide to the NCCN’s COVID-19 and Cancer Guidelines

Article

Here are the key points to know about the National Comprehensive Cancer Network’s guidelines on treating cancer during the COVID-19 pandemic.

NCCN COVID-19 guidelines infographic

The National Comprehensive Cancer Network (NCCN) recently published guidelines on the care of patients with cancer during the coronavirus disease 2019 (COVID-19) pandemic. Here is a snapshot of what they recommend on:

  • Vaccines for patients with cancer: The NCCN recommends that patients with cancer — and their caregivers — receive the vaccination whenever they are eligible to do so. The organization even advocated that cancer survivors be prioritized in vaccine distribution. There are certain exceptions, however, like patients undergoing certain treatments for hematologic malignancies.
  • Cancer treatment delays: Current research shows that immunotherapy, hormone therapy, and radiation 1 month prior to COVID-19 exposure does not correlate with increased mortality. However, if a patient is on a cytotoxic chemotherapy and tests positive for COVID-19, they may need to delay treatment.
  • Antibody testing: After receiving the COVID-19 vaccine, there is currently no need to undergo continuous antibody testing, according to the NCCN.

For the latest updates on COVID-19 and cancer — and all things oncology nursing — subscribe to Oncology Nursing News.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background